Expression Signature as a Biomarker for Prenatal Diagnosis of Trisomy 21
暂无分享,去创建一个
Borut Peterlin | Aleš Maver | Luca Lovrečić | Peter Juvan | P. Juvan | B. Peterlin | A. Maver | M. Volk | L. Lovrečić | Marija Volk
[1] Arnold J. Stromberg,et al. Statistical implications of pooling RNA samples for microarray experiments , 2003, BMC Bioinform..
[2] J. Haerting,et al. Gene-expression signatures in breast cancer. , 2003, The New England journal of medicine.
[3] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[4] Ingo Ruczinski,et al. Primary and secondary transcriptional effects in the developing human Down syndrome brain and heart , 2005, Genome Biology.
[5] Marc S Williams,et al. Rapid ACCE: Experience with a rapid and structured approach for evaluating gene-based testing , 2007, Genetics in Medicine.
[6] J M Delabar,et al. Classification of human chromosome 21 gene-expression variations in Down syndrome: impact on disease phenotypes. , 2007, American journal of human genetics.
[7] N. Hastie,et al. Transcriptome analysis of human autosomal trisomy. , 2002, Human molecular genetics.
[8] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[9] Y. Yaron,et al. Genome-wide expression analysis of cultured trophoblast with trisomy 21 karyotype. , 2007, Human reproduction.
[10] H. Lehrach,et al. Meta-analysis of heterogeneous Down Syndrome data reveals consistent genome-wide dosage effects related to neurological processes , 2011, BMC Genomics.
[11] Anne-Laure Boulesteix,et al. CMA – a comprehensive Bioconductor package for supervised classification with high dimensional data , 2008, BMC Bioinformatics.
[12] Maqc Consortium. The MicroArray Quality Control ( MAQC )-II study of common practices for the development and validation of microarray-based predictive models , 2012 .
[13] R. Quatrano. Genomics , 1998, Plant Cell.
[14] A. Holland,et al. Gene expression profiling in the adult Down syndrome brain. , 2007, Genomics.
[15] M. Delorenzi,et al. Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. , 2007, American journal of human genetics.
[16] F. Hsieh,et al. Gene expression variation increase in trisomy 21 tissues , 2008, Mammalian Genome.
[17] B. Tycko,et al. Cell type-specific over-expression of chromosome 21 genes in fibroblasts and fetal hearts with trisomy 21 , 2006, BMC Medical Genetics.
[18] Donna K Slonim,et al. Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses , 2009, Proceedings of the National Academy of Sciences.
[19] L. Vitale,et al. Gene Expression Profile Analysis in Human T Lymphocytes from Patients with Down Syndrome , 2004, Annals of human genetics.
[20] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[21] Dario Greco,et al. Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy , 2007, BMC Genomics.
[22] A. Dufke,et al. Specific transcriptional changes in human fetuses with autosomal trisomies , 2008, Cytogenetic and Genome Research.